Author

Vandana Sharma

University of WyomingORCID 0000-0002-2676-3239Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Vandana Sharma2 papers · London School of Hygiene & Tropical Medicine

Biology Disciplines

Click to filter author papers

Neuroscience· 2 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1

Frequent Co-Authors

Rammohan ShuklaiD· 2 shared Akiko SumitomoiD· 1 shared Anuj ChoudharyiD· 1 shared Barbara GisabellaiD· 1 shared David A. LewisiD· 1 shared Elena Payna· 1 shared Etienne L. SibilleiD· 1 shared Eun Seok ChoiiD· 1 shared

Activity by Year

2025-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 17 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersNeuroscience

Rammohan ShuklaORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Polysome Profiling Method for Low-Input Human Postmortem Brain

Vandana Sharma, Anuj Choudhary, Mrunali Dinesh Dhokne, Barbara Gisabella, Harry Pantazopoulos, Rammohan Shukla

This paper develops a low-input polysome profiling protocol for human postmortem brain tissue and adapts it for neuronal cell lines and mouse brain.

bioRxiv · May 29, 2026 · PreprintNeuroscience

Molecular Characterization of the Progressive Landscape of Depression

Vandana Sharma, Elena Payna, Samuel González García, Lauren Fang, Kiran Boyinepally, Akiko Sumitomo, Toshifumi Tomoda, David A. Lewis, Robert Erne McCullumsmith, Etienne L. Sibille, Rammohan Shukla

This study identifies progressive molecular differences in depression across clinical stages using RNA-seq data, revealing shared and distinct pathways and cell-type-specific changes associated with symptom dimensions and therapeutic targets.

bioRxiv · May 23, 2026 · PreprintNeuroscience

Immunogenic shift of arginine metabolism triggers systemic metabolic and immunological reprogramming to prevent HER2+ breast cancer

Vandana Sharma, Veani Fernando, Xunzhen Zheng, Eun Seok Choi, Osama Sweef, Venetia D. Thomas, Justin Szpendyk, Saori Furuta

This study shows that long-term SEP treatment prevents HER2+ breast cancer by reprogramming systemic metabolism and immunity, increasing memory T cell formation.

Cancer & Metabolism · Mar 20, 2025Peer-reviewedCancer Biology